首页|超声引导下重复细针穿刺活检术对Bethesda Ⅲ类甲状腺结节临床管理的影响

超声引导下重复细针穿刺活检术对Bethesda Ⅲ类甲状腺结节临床管理的影响

Impact of ultrasound-guided repeated fine-needle aspiration biopsy on the clinical management of Bethesda Ⅲ thyroid nodules

扫码查看
目的 研究超声引导下细针穿刺细胞学检查(fine-needle aspiration biopsy,FNAB)为Bethesda Ⅲ类甲状腺结节重复细针穿刺细胞学检查(repeated fine-needle aspiration biopsy,rFNAB)的时机及特征,并进一步优化穿刺方案.方法 回顾性分析中日联谊医院甲状腺外科2020年12月至2022年12月初次FNAB结果为Bethesda Ⅲ类,行rFNAB的71例(73枚结节)患者资料,女57例,男14例,年龄(45.7±10.4)岁.按照rFNAB结果将结节进行分组,Bethesda Ⅱ为良性组21枚、Bethesda Ⅴ/Ⅵ为恶性组39枚,以上两组统划为诊断明确组,其余分类为非明确诊断组13枚.记录rFNAB结果、穿刺间隔时间、术后病理、超声特征、FNAB特征等.计数资料用百分比和数字表示,计量资料用平均数±标准差((x)±s)表示,应用x2检验或Fisher精确检验等统计方法分析.结果 本研究对73枚Bethesda Ⅲ类甲状腺结节进行了rFNAB,结果显示60枚(82.2%)结节得到明确诊断,13枚(17.8%)结节未非明确诊断.恶性组的钙化特征与良性组、非诊断组之间差异具有统计学意义(P<0.05).在恶性组中,29例接受手术治疗,初次FNAB后间隔时间超过3个月再手术治疗的患者中仅2例(8.0%),复发风险为中危.重新审查rFNAB恶性组的31个初次穿刺样本,其中9个(29%)镜下细胞轻度异型,22个(71.0%)取材不良,多以纤维及钙化成分为主.结论 初次FNAB为Bethesda Ⅲ类的结节在超过3个月随访后,新增或持续存在可疑超声征象尤其是存在微钙化征象时应行rFNAB,但穿刺时应针对结节边缘非钙化区进行多点穿刺,以提高rFNAB的准确性和可靠性.
Objective To investigate the timing and features of fine-needle aspiration biopsy(FNAB)guided by ultrasound for Bethesda Ⅲ thyroid nodules and to further optimize the puncture scheme.Methods A retrospective analysis was conducted on data from patients who underwent rFNAB for Bethesda Ⅲ thyroid nodules at the China-japan Union Hospital of Jilin University Thyroid Surgery Department from Dec.2020 to Dec.2022.The study included 71 cases(73 nodules),consisting of 57 females and 14 males,with an average age of(45.7±10.4)years.Patients were grouped based on rFNAB results:Bethesda Ⅱ as the benign group(n=21),Bethesda Ⅴ/Ⅵ as the malignant group(n=39),and the remaining cases categorized as the indeterminate group(n=13).Data on rFNAB results,puncture interval time,postoperative pathology,ultrasound features,and FNAB characteristics were recorded.Descriptive statistics were used for categorical data,presented as percentages and numbers,while contin-uous data were presented as mean±standard deviation((x)±s).The x2 test or Fisher's exact test was applied for analysis.Results In this study,rFNAB was performed on 73 Bethesda Ⅲ thyroid nodules.The results showed that 60 nodules(82.2%)received a definite diagnosis,while 13 nodules(17.8%)were indeterminate.There was a sta-tistically significant difference in the calcification classification between the malignant group and the benign group as well as the indeterminate group(P<0.05).Among the malignant group,29 patients underwent surgical treat-ment,with only 2 cases(8.0%)showing intermediate recurrence risk when surgery was performed more than three months after the initial FNAB.Upon reevaluation of the 31 initial FNAB samples from the malignant group,9 sam-ples(29.0%)exhibited mild cytological atypia,and 22 samples(71.0%)had poor quality specimens,mainly com-prising fibrous and calcified components.Conclusions For nodules initially classified as Bethesda Ⅲ,if suspi-cious ultrasound features persist or emerge,especially if microcalcifications are present,rFNAB should be per-formed after a follow-up period exceeding three months.However,during the puncture,multiple points should be targeted at the non-calcified areas of the nodule to enhance the accuracy and reliability of rFNAB.

Thyroid noduleFine-needle aspiration biopsy

张帅、付庆锋、何润东、孙平、孙辉、周乐

展开 >

吉林大学中日联谊医院甲状腺外科吉林省外科转化医学重点实验室 吉林省甲状腺疾病防治工程实验室,长春 130033

甲状腺结节 细针穿刺细胞学检查

吉林省财政厅项目

2019SCZ029

2024

中华内分泌外科杂志
中华医学会

中华内分泌外科杂志

CSTPCD
影响因子:0.657
ISSN:1674-6090
年,卷(期):2024.18(4)